Evidence map›Paper›PMID 37549859›Full record

ReviewCellular signalling2023

Ca

Samar Sayedyahossein, Louise Thines, David B Sacks

Open access · greenAbstract readReview
In one paragraph

Review in Cellular signalling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Prostaglandin EbioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. RNAi-MediatedInsects · 2024
    Article
  14. Pannexin 1 crosstalk with the Hippo pathway in malignant melanoma.bioRxiv : the preprint server for biology · 2024
    Article
  15. Article
  16. Article
  17. The role of mechanically sensitive ion channel Piezo1 in bone remodeling.Frontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Samar SayedyahosseinDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA.
Louise ThinesDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA.
David B SacksDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, MD, USA. Electronic address: david.sacks2@nih.gov.
National Institutes of Health · US

Funding

IQGAP1 in tumorigenesisZIACL080017 · CLC · CLINICAL CENTER · PI SACKS, DAVID · 2012 to 2025
$0k
Intramural NIH HHS ZIA CL080017
6 · The paper itself

Abstract

The Hippo signaling pathway is a master regulator of organ size and tissue homeostasis. Hippo integrates a broad range of cellular signals to regulate numerous processes, such as cell proliferation, differentiation, migration and mechanosensation. Ca

Indexed as

Hippo Signaling PathwayProtein Serine-Threonine KinasesCell DifferentiationCell ProliferationSignal TransductionProtein Serine-Threonine KinasesCalciumCalmodulinHippoS100SignalingYAP

Identifiers

PMID37549859
PMCPMC10529277
OpenAlexW4385613043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.